Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer. - Wikidata - wikimedia - TriplyDB

Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.

Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.

http://www.wikidata.org/entity/Q37209259

about

Matrix crosslinking forces tumor progression by enhancing integrin signaling Complexities of TGF-β targeted cancer therapy.Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.The roles of TGFβ in the tumour microenvironment.TGF-beta biology in mammary development and breast cancer.Transforming growth factor beta (TGF-beta) and inflammation in cancer.Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women.An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer.TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression Quantitative analysis of the secretome of TGF-beta signaling-deficient mammary fibroblasts.The role of the microenvironment in mammary gland development and cancer.Roles of tumor suppressors in regulating tumor-associated inflammation.Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populations.Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression.Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-β signaling.Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761.Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway.The role of cytokines in breast cancer development and progression Breast cancer at bone metastatic sites: recent discoveries and treatment targets.Side populations from cervical-cancer-derived cell lines have stem-cell-like properties.The colorectal tumor microenvironment: the next decade.PDGFRα and β play critical roles in mediating Foxq1-driven breast cancer stemness and chemoresistance.Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.Engineered three-dimensional microfluidic device for interrogating cell-cell interactions in the tumor microenvironment.Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties.Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.The complexities of TGF-β action during mammary and squamous cell carcinogenesis.Targeting the TGFβ signalling pathway in disease.Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade glioma Role of TGF-β and the tumor microenvironment during mammary tumorigenesis Luminal breast cancer metastasis is dependent on estrogen signaling.Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment.Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-кB target genes in human breast cancer

P2860

Q24646370-9B0CED22-F708-4812-AC28-8C5F85E91245 Q27693607-3ED3C8D6-B14C-4751-A78E-52001EB74438 Q28386225-2873FD5B-89B6-41B8-A695-36595BBF53FD Q30544282-009BAB17-0BCD-4B6B-B016-DBE77B037F40 Q30572945-9B97BA60-FE32-40FB-A92A-057EAD2D05CD Q30829535-0AD49215-0459-4218-B15A-5EC2867AF7D4 Q33630845-8B76A2A8-6B70-410A-BF72-C8421F60D335 Q33681686-1A3C2361-26A3-4B9A-B469-C4097DBD3C91 Q33712568-25AA2DF4-D982-45BB-A304-133FFE7BBFBC Q33869600-11526ADD-A577-4310-B388-B8DCE7E51AFC Q33892460-7D800795-8523-464A-A6D4-3A637E4679FA Q33892756-416CA596-DEF9-4ECC-82BD-50EBEBEE2D15 Q33936542-E9DED5E3-B59D-49D1-BEA8-48A26A00AB45 Q34145178-046F7F11-8948-4047-90B6-8146C3AC86FA Q34241137-9C5628D7-02C8-4CF2-9E9F-47E2550E8E14 Q34413441-0200253D-3444-4478-A436-D1F04F6DF6B6 Q34485047-B5EF4D13-A19E-4F77-A541-57B7AE288455 Q34516142-0AD208B5-8F89-4ABB-961E-C1C60AB633D7 Q34585721-05EC6B4A-F7B7-49F2-8123-755FF95F015B Q34687503-AB5529E2-689F-4765-A579-CF7027948A4B Q34731294-698A8C4F-B823-45C7-A6A4-202409CFC71F Q34920381-2393C22B-23DF-46EC-B413-5EC0F6345B1D Q34939979-F19CB679-5A56-4594-B984-2BF8770BC67E Q35085092-7F10000D-54A1-44FA-8856-2E078FF8AC38 Q35206661-2E66D9F8-53BD-471E-B2B1-2F0389F959D2 Q35262501-66502A0C-4A79-41B7-B837-5A5C92328B31 Q35369888-CB5D458E-1B55-40A2-987C-42FC0D61161B Q35402234-E5E64554-00EA-4022-B4B7-B3E5F32654D9 Q35490960-4ED5FC02-0C73-4263-9EDE-22973DD4C007 Q35814020-7109736D-4E2A-4287-A7AF-3F00680D140D Q36188900-A0BBA3BF-34FE-4B0F-96FE-6BE0D4E68B0C Q36245556-01EE5723-1C8B-4C3B-B68C-9CF01244996C Q36462328-6E5651CC-6542-463F-9398-A6750B809B0E Q36462348-59D47B32-4612-4E85-A6FB-D59BE33BE625 Q36977668-324418E2-EC07-47D8-9674-79B41BA1847E Q37044604-D32A606B-309F-410D-B153-F894C8815D66 Q37276323-BA50F509-B45C-49D6-93E1-4EA46D1BCA81 Q37529876-731A0ECE-F7EC-4BE4-9231-AA5D3F5792B2 Q37580230-10CC2053-3FB0-4F89-9D8A-F15A30D3D35C Q37649660-2D8E807B-68AA-4CB7-B5F2-53AD11C3D205

P2860

Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.

http://www.wikidata.org/entity/Q37209259

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Abrogation of TGF-beta signali ...... gnosis in human breast cancer.

@en

Abrogation of TGF-beta signali ...... gnosis in human breast cancer.

@nl

type

label

Abrogation of TGF-beta signali ...... gnosis in human breast cancer.

@en

Abrogation of TGF-beta signali ...... gnosis in human breast cancer.

@nl

prefLabel

Abrogation of TGF-beta signali ...... gnosis in human breast cancer.

@en

Abrogation of TGF-beta signali ...... gnosis in human breast cancer.

@nl

P1433

Q37209259-A9FF818A-2C9F-40F3-866D-AA5E5FA79538

P1476

Q37209259-5D5D3739-5F39-498C-AC08-7B55A44F6AAF

P2093

Q37209259-16EA6A66-ECFE-4B8D-B928-9E0CC1A27163

Q37209259-1FE7A13B-399F-4829-95A8-4D1A4396B6FC

Q37209259-99E3EBEC-29F6-4C25-9699-55CA026D9BE8

Q37209259-D2C60A8D-FDF2-4C79-8C08-CAC95E6C53D1

Q37209259-D445C296-57B0-4637-ACC0-96AE273164E2

Q37209259-EB5B8DF5-EC03-4F81-812B-492D9DF94872

Q37209259-F5406F3C-F947-40F3-848C-E2F4452F0E7F

P2860

Q37209259-00A380F1-3226-4532-8629-7D76B76D5888

Q37209259-04DF6BCD-9C87-4C4A-B0A5-EFC571B8B7CA

Q37209259-08C89942-9B0C-4974-84C7-9AD8083569AF

Q37209259-0EE89371-AF13-4757-B8F8-EB4B7FF02101

Q37209259-119DB647-D9FA-470E-BE2D-D1E2861315D7

Q37209259-14C10E0B-C427-49EB-9228-A029E6D41584

Q37209259-17DB18CD-9D5F-41EC-B1BD-3925E9D9C1BE

Q37209259-3819AAEE-50D1-4D9C-811F-4AB32D809166

Q37209259-3F4F5589-455D-4093-8961-2148062A4BAD

Q37209259-4273E960-382F-49F7-86C3-FD057E4694A2

P304

Q37209259-0800A7FE-9E71-416D-AE12-77E326B8BCE3

P31

Q37209259-B875948E-BF8D-4C1C-9C2C-5DD6050FBEF0

P356

Q37209259-4BCFCD48-9288-4DAD-89B0-1A1CBA7D6D97

P407

Q37209259-B64757B2-9FF0-4ECD-983D-24FB263C20CF

P433

Q37209259-6CACE9E4-491E-4CC9-AF8E-3AC2EF955F03

P478

Q37209259-3836A7DF-D3E7-47B0-AC74-C9EC5B1FCF89

P50

Q37209259-10365E7D-E053-4F03-9910-2025A8FCAC3D

Q37209259-57481B6D-A1AD-402C-AD77-3B6A369CED8C

P577

Q37209259-99D8959A-4A4E-4DDC-ABDD-8A8FCC9DDAD8

P698

Q37209259-44C336C4-CAEC-4FD2-B3E9-0BE3ACED5591

P932

Q37209259-10531A42-8A08-43A2-9986-575126D42D04

P356

P1433

Journal of Clinical Investigation

P1476

Abrogation of TGF-beta signali ...... gnosis in human breast cancer.

@en

P2093

Anna Chytil

http://www.w3.org/2001/XMLSchema#string

Christine H Chung

http://www.w3.org/2001/XMLSchema#string

Daniel G Stover

http://www.w3.org/2001/XMLSchema#string

Joel S Parker

http://www.w3.org/2001/XMLSchema#string

Mary Aakre

http://www.w3.org/2001/XMLSchema#string

Nikki Cheng

http://www.w3.org/2001/XMLSchema#string

Yu Shyr

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of chemokine receptors in breast cancer metastasis

Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab

Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis

Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiling predicts clinical outcome of breast cancer

A gene-expression signature as a predictor of survival in breast cancer

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

Molecular portraits of human breast tumours

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

P304

1571-1582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI37480

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Harold L. Moses

P577

2009-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19451693

http://www.w3.org/2001/XMLSchema#string

P932

2689133

http://www.w3.org/2001/XMLSchema#string